Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill

Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill

Severe forms of coronavirus 2019 (COVID-19) disease are caused by an exaggerated systemic inflammatory response and subsequent inflammation-related coagulopathy. Anti-inflammatory treatment with low dose dexamethasone has been shown to reduce mortality in COVID-19 patients requiring oxygen therapy....

Full description

Bibliographic Details
Main Authors: Mélanie Dechamps, Julien De Poortere, Marie Octave, Audrey Ginion, Valentine Robaux, Laurence Pirotton, Julie Bodart, Damien Gruson, Marie-Astrid Van Dievoet, Jonathan Douxfils, Hélène Haguet, Laure Morimont, Marc Derive, Lucie Jolly, Luc Bertrand, Pierre-François Laterre, Sandrine Horman, Christophe Beauloye
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:International Journal of Molecular Sciences
Subjects:
COVID-19
low dose dexamethasone
inflammation
coagulopathy
cytokine storm
Online Access:https://www.mdpi.com/1422-0067/24/8/7278

Internet

https://www.mdpi.com/1422-0067/24/8/7278

Similar Items